Rahayu Mahzam on conditions under Chronic Disease Management Programme
Conditions under the Chronic Disease Management Programme (CDMP) are regularly reviewed by the Clinical Advisory Committee (CAC). Most recently, gout, allergic rhinitis and chronic hepatitis B were added to the CDMP from July 2022. In selecting the conditions for review, feedback and requests from medical professionals, the public and MPs are taken into account. The CAC consults clinical experts and considers factors such as disease prevalence, potential benefits of early intervention to patients' outcomes and the availability of evidence-based clinical guidelines for appropriate care of the condition. Senior Parliamentary Secretary for Health Rahayu Mahzam said this in reply to an MP’s questions in Parliament on Tuesday (Feb 6).
Conditions under the Chronic Disease Management Programme (CDMP) are regularly reviewed by the Clinical Advisory Committee (CAC). Most recently, gout, allergic rhinitis and chronic hepatitis B were added to the CDMP from July 2022. In selecting the conditions for review, feedback and requests from medical professionals, the public and MPs are taken into account. The CAC consults clinical experts and considers factors such as disease prevalence, potential benefits of early intervention to patients' outcomes and the availability of evidence-based clinical guidelines for appropriate care of the condition. Senior Parliamentary Secretary for Health Rahayu Mahzam said this in reply to an MP’s questions in Parliament on Tuesday (Feb 6).